Inhibition of thrombin-induced platelet aggregation by uteroglobin.
Uteroglobin, a steroid-dependent, small molecular weight (15K) protein in the rabbit, inhibited thrombin-induced aggregation of both rabbit and human gel-filtered platelets (GFP). GFP aggregation by arachidonic acid was not affected by uteroglobin. There were no effects of uteroglobin on thrombin-induced clotting of plasma or purified fibrinogen, or inhibition of thrombin by antithrombin III. Additionally, preliminary results suggest that uteroglobin does not interfere with binding of thrombin to platelets. We suggest that inhibition of platelet aggregation by uteroglobin may function in preventing thrombosis and ensuring free flow of blood through the microvasculature of the uterus and the placenta and may induce some of the antimotility effects of progesterone on the uterus.
D000818:Animals; D005260:Female; D006023:Glycoproteins / Q000494:pharmacology*; D006801:Humans; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D010974:Platelet Aggregation / Q000187:drug effects*; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology; D011817:Rabbits; D013917:Thrombin / Q000494:pharmacology*; D014598:Uteroglobin / Q000494:pharmacology*
D006023:Glycoproteins; D011374:Progesterone; D014598:Uteroglobin; D010741:Phospholipases A; D013917:Thrombin